Where Will Palantir Stock Be in 2030?

Palantir’s U.S. commercial revenue growth remains extremely strong, up 149% YoY in Q2 2026, but the article warns the stock likely won’t replicate its past multibagger returns given a lofty valuation (about 73x trailing sales) and expectations risk. Analysts project revenue rising 83% this fiscal year to $8.2B, then 49% to $12.2B next fiscal year, with potential 2030 sales of ~$24B under continued ~40% growth assumptions. The key takeaway is AI-led growth momentum continues, but valuation compression risk could limit upside versus expectations.

Analysis

The key issue is not whether the business is executing; it is whether execution can keep outrunning expectation compression. At ~73x trailing sales, the stock already discounts several years of near-flawless commercialization, so even very strong growth can still translate into mediocre forward returns if the multiple drifts toward software peers in the 20-40x range.

The more interesting second-order effect is budget reallocation inside enterprise AI. If Palantir keeps winning as a secure application layer, it likely takes share from systems integrators and fragmented point solutions rather than creating entirely new spend, which limits total market expansion. That makes the upside more path-dependent on customer adds and expansion in the U.S. commercial base than on headline AI enthusiasm, and it raises the risk that growth decelerates faster than investors expect once easy pilot conversions are exhausted.

Near term, the stock can still trade well because momentum and narrative remain powerful, but the next 1-3 months are about guide quality, not history. The contrarian view is that consensus may be underestimating the durability of Palantir’s government cash flows and the company’s ability to become a default enterprise AI control plane; that would matter if commercial growth stays above 75-100% for several quarters. The thesis breaks if commercial growth decelerates sharply, net new customer adds stall, or the market starts valuing the name like a mature platform rather than a hypergrowth winner.

Key Decisions for Investors

• Do not chase PLTR here; use strength to trim or hold only core exposure. At current valuation, the risk/reward skews poorly unless commercial growth stays >75% y/y for multiple quarters.
• Relative-value trade: short PLTR / long NVDA into post-earnings strength. Rationale: NVDA has better visibility into infrastructure demand and less multiple-compression risk; this is cleaner if AI spend rotates from applications back to picks-and-shovels.
• If already long PLTR, hedge with near-dated put spreads into the next earnings event rather than outright selling. The catalyst is guidance quality and customer acceleration, not headline revenue already in the model.
• Watch for a 15-20% drawdown or a forward-sales multiple below ~50x before initiating new longs. That is the zone where growth can still outrun valuation decay over a 12-18 month horizon.
• Falsifier alert: if U.S. commercial customer growth and sequential revenue expansion remain extreme in the next two quarters, cover shorts quickly; the market will keep rewarding duration if the company proves it can scale beyond the current customer base.